EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

MDM2 Regulation of HIF Signaling Causes Microvascular Dysfunction in Hypertrophic Cardiomyopathy

Puneeth Shridhar, Michael S Glennon, Soumojit Pal iD, Christina J Waldron, Ethan J Chetkof, Payel Basak, Nicolas G Clavere, Dipanjan Banerjee iD, Sebastien Gingras iD, Jason R Becker iD

Circulation · 05.12.2023 · 148 (23) · 1870-1886

DOI: 10.1161/circulationaha.123.064332 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, erschienen am 05.12.2023. Verfasst von Puneeth Shridhar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Medicine, and Pittsburgh Heart, Lung, Blood and Vascular Medicine Institute (P.S., M.S.G., S.P., C.J.W., E.J.C.…. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-mdm2, Cardiomyopathy, Hypertrophic. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Microvasculature dysfunction is a common finding in pathologic remodeling of the heart and is thought to play an important role in the pathogenesis of hypertrophic cardiomyopathy (HCM), a disease caused by sarcomere gene mutations. We hypothesized that microvascular dysfunction in HCM was secondary to abnormal microvascular growth and could occur independent of ventricular hypertrophy. METHODS: We used multimodality imaging methods to track the temporality of microvascular dysfunction in HCM mouse models harboring mutations in the sarcomere genes Mybpc3 (cardiac myosin binding protein C3) or Myh6 (myosin heavy chain 6). We performed complementary molecular methods to assess protein quantity, interactions, and post-translational modifications to identify mechanisms regulating this response. We manipulated select molecular pathways in vivo using both genetic and pharmacological methods to validate these mechanisms. RESULTS: We found that microvascular dysfunction in our HCM models occurred secondary to reduced myocardial capillary growth during the early postnatal time period and could occur before the onset of myocardial hypertrophy. We discovered that the E3 ubiquitin protein ligase MDM2 (murine double minute 2) dynamically regulates the protein stability of both HIF1α (hypoxia-inducible factor 1 alpha) and HIF2α (hypoxia-inducible factor 2 alpha)/EPAS1 (endothelial PAS domain protein 1) through canonical and noncanonical mechanisms. The resulting HIF imbalance leads to reduced proangiogenic gene expression during a key period of myocardial capillary growth. Reducing MDM2 protein levels by genetic or pharmacological methods normalized HIF protein levels and prevented the development of microvascular dysfunction in both HCM models. CONCLUSIONS: Our results show that sarcomere mutations induce cardiomyocyte MDM2 signaling during the earliest stages of disease, and this leads to long-term changes in the myocardial microenvironment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-mdm2Cardiomyopathy, HypertrophicMiceAnimalsMyocardiumMyocytes, CardiacSarcomeresMutationHypertrophyMyosin Heavy Chains

Stichwörter der Autor:innen

capillariescardiomyopathy, hypertrophichypoxiamyocardiummyosin heavy chainsproteasome endopeptidase complexsarcomere

Substanzen

Proto-Oncogene Proteins c-mdm2Myosin Heavy Chains

Autor:innen und Institutionen

  • Division of Cardiology, Department of Medicine, and Pittsburgh Heart, Lung, Blood and Vascular Medicine Institute (P.S., M.S.G., S.P., C.J.W., E.J.C., P.B., N.C.G., D.B., J.R.B.), University of Pittsburgh School of Medi…
  • Department of Bioengineering, Swanson School of Engineering, University of Pittsburgh, PA (P.S., J.R.B.).
  • Department of Immunology (S.G.), University of Pittsburgh School of Medicine and University of Pittsburgh Medical Center, PA.

ORCID-Profile: Soumojit Pal, Dipanjan Banerjee, Sebastien Gingras, Jason R Becker

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Shridhar, P., Glennon, M. S., Pal, S., Waldron, C. J., Chetkof, E. J., Basak, P., Clavere, N. G., Banerjee, D., Gingras, S., & Becker, J. R. (2023). MDM2 Regulation of HIF Signaling Causes Microvascular Dysfunction in Hypertrophic Cardiomyopathy. Circulation, 148(23), 1870-1886. https://doi.org/10.1161/circulationaha.123.064332

Vancouver

Shridhar P, Glennon MS, Pal S, Waldron CJ, Chetkof EJ, Basak P, et al. MDM2 Regulation of HIF Signaling Causes Microvascular Dysfunction in Hypertrophic Cardiomyopathy. Circulation. 2023;148(23):1870-1886. doi:10.1161/circulationaha.123.064332

BibTeX
@article{Shridhar2023,
  author = {Shridhar, Puneeth and Glennon, Michael S and Pal, Soumojit and Waldron, Christina J and Chetkof, Ethan J and Basak, Payel and Clavere, Nicolas G and Banerjee, Dipanjan and Gingras, Sebastien and Becker, Jason R},
  title = {MDM2 Regulation of HIF Signaling Causes Microvascular Dysfunction in Hypertrophic Cardiomyopathy},
  journal = {Circulation},
  year = {2023},
  volume = {148},
  number = {23},
  pages = {1870--1886},
  doi = {10.1161/circulationaha.123.064332}
}
Kostenlos starten →